Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer's Disease
Lih‐Fen Lue(Banner Sun Health Research Institute), Joseph Rogers(Banner Sun Health Research Institute), Yu‐Min Kuo(National Yang Ming Chiao Tung University), Janice Kurth, Thomas G. Beach(Banner Sun Health Research Institute), Libuse Brachova(Banner Sun Health Research Institute), Alex E. Roher(Barrow Neurological Institute), Yong Shen(NewYork–Presbyterian Hospital), Russel E. Rydel, Lucia I. Sue(Banner Sun Health Research Institute)
Cited by 1,525
Related Papers
National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease
|Alzheimer s & Dementia|2012|3.2k
National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach
|Acta Neuropathologica|2011|2.9k
Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup
|Alzheimer s & Dementia|2024|2.3k
Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature
|Journal of Neuropathology & Experimental Neurology|2012|2.1k